Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2198-6584
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis ; volume:7 ; number:1 ; day:6 ; month:1 ; year:2020 ; pages:165-171 ; date:3.2020
Rheumatology and therapy ; 7, Heft 1 (6.1.2020), 165-171, 3.2020

Creator
Best, Jennie H.
Vlad, Steven C.
Pei, Jinglan
Contributor
SpringerLink (Online service)

DOI
10.1007/s40744-019-00191-6
URN
urn:nbn:de:101:1-2020051301200679525039
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Best, Jennie H.
  • Vlad, Steven C.
  • Pei, Jinglan
  • SpringerLink (Online service)

Other Objects (12)